Bioactive polymer scaffold for fabrication of vascularized engineering tissue

Journal of Artificial Organs

Volumn 15, Issue 3, 2012, Pages 215-224

  Sukmana, Irza ^a,b  

^a UNIVERSITI TEKNOLOGI MALAYSIA   (Malaysia)

^b UNIVERSITY OF LAMPUNG   (Indonesia)

Author keywords

Angiogenesis; Bioactive polymer; Scaffold vascularization; Tissues engineering

Indexed keywords

ALBUMIN; ALGINIC ACID; BIOMATERIAL; CELLULOSE; CHITOSAN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; DEXTRAN; FIBRIN; FIBRIN GLUE; FIBRINOGEN; FIBROBLAST GROWTH FACTOR; GELATIN; HYALURONIC ACID; LACTIC ACID; POLITEF; POLYETHYLENE TEREPHTHALATE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; TISSUE SCAFFOLD; VASCULOTROPIN;

ANGIOGENESIS; BIOMECHANICS; CELL DIFFERENTIATION; CELL EXPANSION; CELL MIGRATION; EQUIPMENT DESIGN; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; ORGAN TRANSPLANTATION; POROSITY; PRIORITY JOURNAL; REVIEW; RIGIDITY; SKIN GRAFT; TISSUE ENGINEERING; VASCULARIZATION;

ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84868377607     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-012-0644-6     Document Type: Review

References (107)

1. Atala A. Tissue engineering and regenerative medicine: concepts for clinical application. Rejuvenation Res. 2004;7:15-31.
2. Orlando G, Wood KJ, Stratta RJ, Atala A, Soker S. Regenerative medicine and organ transplantation: past, present, and future. Transplantation. 2011;91:1310-7.
3. Jain RK. Molecular regulation of vessel maturation. Nat Med. 2003;9:685-93.
4. Neumann T, Nicholson BS, Sanders JE. Tissue engineering of perfused microvessels. Microvasc Res. 2003;66:59-67.
5. Godbey WT, Atala A. In vitro systems for tissue engineering. Ann N Y Acad Sci. 2002;961:10-26.
6. Mikos AG, Sarakinos G, Lyman MD, Ingber DE, Vacanti JP, Langer R. Prevascularization of porous biodegradable polymers. Biotechnol Bioeng. 1993;42:716-23.
7. Levenberg S, Langer R. Advances in tissue engineering. Curr Top Dev Biol. 2004;61:113-34.
8. Nerem RM. Cell-based therapies: from basic biology to replacement, repair, and regeneration. Biomaterials. 2007;28:5074-7.
9. He W, Ye L, Li S, Liu H, Wu B, Wang Q, et al. Construction of vascularized cardiac tissue from genetically modified mouse embryonic stem cells. J Heart Lung Transplant. 2012;31:204-12.
10. Koh CJ, DeloDM, Lee JW, SiddiquiMM, Lanza RP, Soker S,Yoo JJ, Atala A. Parthenogenesis-derived multipotent stem cells adapted for tissue engineering applications. Methods. 2009;47:90-7.
11. Conway EM, Carmeliet P. The diversity of endothelial cells: a challenge for therapeutic angiogenesis. Genome Biol. 2004;5:207.
12. Gimble J, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy. 2003;5:362-9.
13. Langer R, Vacanti JP. Tissue engineering. Science. 2003;260: 920-6.
14. Howe A, Aplin AE, Alahari SK, Juliano RL. Integrin signaling and cell growth control. Curr Opin Cell Biol. 1998;10:220-3.
15. Frescaline G, Bouderlique T, Huynh MB, Papy-Garcia D, Courty J, Albanese P. Glycosaminoglycans mimetics potentiate the clonogenicity, proliferation, migration and differentiation properties of rat mesenchymal stem cells. Stem Cell Res. 2012;8:180-92.
16. Chang C, Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 2001;11:S37-43.
17. Bach FH. Xenotransplantation: problems and prospects. Annu Rev Med. 1998;49:301-10.
18. Lee CH, Huang GS, Chao KH, Wu SS, Chen Q. Differential pretensions of a flexor tendon graft for anterior cruciate ligament reconstruction: a biomechanical comparison in a porcine knee model. Arthroscopy. 2005;21:540-6.
19. Fuchs JR, Nasseri BA, Vacanti JP. Tissue engineering: a 21st century solution to surgical reconstruction. Ann Thorac Surg. 2001;72:577-91.
20. Chaikof EL, Matthew H, Kohn J, Mikos AG, Prestwich GD, Yip CM. Biomaterials and scaffolds in reparative medicine. Ann N Y Acad Sci. 2002;961:96-105.
21. Larson JW III, Chu CR. Tissue engineering of articular cartilage. In: Guelcher SA, Hollinger JO, editors. An introduction to biomaterials. 2nd ed. Boca Raton: CRC Press; 2006. p. 525-36.
22. Mooney DJ, Sano K, Kaufmann PM, Majahod K, Schloo B, Vacanti JP, Langer R. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res. 1997;37:413-20.
23. Tabata Y. Biomaterial technology for tissue engineering applications. J R Soc Interface. 2009;6:S311-24.
24. Lee JW, Lan PX, Kim B, Lim G, Cho DW. Fabrication and characteristic analysis of a poly(propylene fumarate) scaffold using micro-stereolithography technology. J Biomed Mater Res B Appl Biomater. 2008;87:1-9.
25. Kikuchi A, Okamoto S, Takahashi S, Asano S, Nishikawa T. Linear chronic cutaneous graft-versus-host disease. J Am Acad Dermatol. 1997;37:1004-6.
26. Vert M, Mauduit J, Li S. Biodegradation of PLA/GA polymers: increasing complexity. Biomaterials. 1994;15:1209-13.
27. Bramfeldt H, Sarazin P, Vermette P. Characterization, degradation, and mechanical strength of poly(D,L-lactide-co-epsiloncaprolactone)-poly(ethylene glycol)-poly(D,L-lactide-co-epsiloncaprolactone). J Biomed Mater Res A. 2007;83:503-11.
28. Grizzi I, Garreau H, Li S, Vert M. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. Biomaterials. 1995;16:305-11.
29. Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, Marini R, van Blitterswijk CA, Mulligan RC, D'Amore PA, Langer R. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 2005;23:879-84.
30. Pego AP, Siebum B, Van Luyn MJ. Preparation of degradable porous structures based on 1,3-trimethylene carbonate and D,Llactide (co)polymers for heart tissue engineering. Tissue Eng. 2003;9:981-94.
31. Pego AP, Van Luyn MJ, Brouwer LA, van Wachem PB, Poot AA, Grijpma DW, Feijen J. In vivo behavior of poly(1,3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with D,L-lactide or epsilon-caprolactone: degradation and tissue response. J Biomed Mater Res A. 2003;67:1044-54.
32. Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res. 2007;100:158-73.
33. Hutchings H, Ortega N, Plouet J. Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J. 2003;17:1520-2.
34. Brekke JH, Goldman SM, Ieska K, Issack P, Bong MR, Tian H. Hyaluronan as a biomaterials. In: Guelcher SA, Hollinger JO, editors. An introduction to biomaterials. 2nd ed. Boca Raton: CRC Press; 2006. p. 219-48.
35. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004;4:528-39.
36. Rao CM, Deb TB, Gupta S, Datta K. Regulation of cellular phosphorylation of hyaluronan binding protein and its role in the formation of second messenger. Biochim Biophys Acta. 1997;1336:387-93.
37. Lesley J, Hascall VC, Tammi M, Hyman R. Hyaluronan binding by cell surface CD44. J Biol Chem. 2000;275:26967-75.
38. Slevin M, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem. 2002;277:41046-59.
39. Miletti-González KE, Chen S, Muthukumaran N, Saglimbeni GN, Wu X, Yang J, Apolito K, Shih WJ, Hait WN, Rodr?́guez-Rodr?́guez L. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res. 2005;65:6660-7.
40. Rauh F, Dornish M. Chitosan. In: Guelcher SA, Hollinger JO, editors. An introduction to biomaterials. 2nd ed. Boca Raton: CRC Press; 2006. p. 249-59.
41. Park YD, Tirelli N, Hubbell JA. Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. Biomaterials. 2003;24:893-900.
42. Zielinski BA, Aebischer P. Chitosan as a matrix for mammalian cell encapsulation. Biomaterials. 1994;15:1049-56.
43. Black AF, Hudon V, Damour O, Germain L, Auger FA. A novel approach for studying angiogenesis: a human skin equivalent with a capillary-like network. Cell Biol Toxicol. 1999;15:81-90.
44. Draget KI, Skjak-Braek G, Smidsrod O. Alginate based new materials. Int J Biol Macromol. 1997;21:47-55.
45. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 2003;24: 4337-51.
46. Smidsrod O, Skjak-Braek G. Alginate as immobilization matrix for cells. Trends Biotechnol. 1990;8:71-8.
47. Becker WM, Kleinsmith LJ, Hardin J. The world of the cell. 7th ed. San Francisco: Pearson/Benjamin Cummings; 2009. p. 229-328.
48. Haarer JC, Dee KC. Proteins and amino acid-derived polymers. In: Guelcher SA, Hollinger JO, editors. An introduction to biomaterials. 2nd ed. Boca Raton: CRC Press; 2006. p. 121-38.
49. Chen CS, Yannas IV, Spector M. Pore strain behaviour of collagen-glycosaminoglycan analogues of extracellular matrix. Biomaterials. 1995;16:777-83.
50. Ma L, Gao C, Mao Z, Zhou J, Shen J. Biodegradability and cellmediated contraction of porous collagen scaffolds: the effect of lysine as a novel crosslinking bridge. J Biomed Mater Res A. 2004;71:334-42.
51. Toman PD, Pieper F, Sakai N, Karatzas C, Platenburg E, de Wit I, Samuel C, Dekker A, Daniels GA, Berg RA, Platenburg GJ. Production of recombinant human type I procollagen homotrimer in the mammary gland of transgenic mice. Transgenic Res. 1999;8:415-27.
52. Sugiura H, Yunoki S, Kondo E, Ikoma T, Tanaka J, Yasuda K. In vivo biological responses and bioresorption of tilapia scale collagen as a potential biomaterial. J Biomater Sci Polym Ed. 2009;20:1353-68.
53. Soker S, Machado M, Atala A. Systems for therapeutic angiogenesis in tissue engineering. World J Urol. 2000;18:10-8.
54. Francis ME, Uriel S, Brey EM. Endothelial cell-matrix interactions in neovascularization. Tissue Eng Part B Rev. 2008;14:19-32.
55. Ingber DE, Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factorstimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol. 1989;109:317-30.
56. Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS, Davis GE, Brooks PC. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol. 2001;154:1069-79.
57. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA. 1997;94:13612-7.
58. Litvinov RI, Gorkun OV, Owen SF, Shuman H, Weisel JW. Polymerization of fibrin: specificity, strength, and stability of knob-hole interactions studied at the single-molecule level. Blood. 2005;106:2944-51.
59. Janmey PA, Winer JP, Weisel JW. Fibrin gels and their clinical and bioengineering applications. Interface. 2009;6:1-10.
60. Herrick S. Fibrinogen. Int J Biochem Cell Biol. 1999;31:741-6.
61. Rowe SL, Lee S, Stegemann JP. Influence of thrombin concentration on the mechanical and morphological properties of cell-seeded fibrin hydrogels. Acta Biomater. 2007;3:59-67.
62. Ferrenq I, Tranqui L, Vailhé B, Gumery PY, Tracqui P. Modelling biological gel contraction by cells: mechanocellular formulation and cell traction force quantification. Acta Biotheor. 1997;45:267-93.
63. Vailhé B, Lecomte M, Wiernsperger N, Tranqui L. The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors. Angiogenesis. 1998;2:331-44.
64. Nehls V, Herrmann R. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. Microvasc Res. 1996;51:347-64.
65. Cox S, Cole M, Tawil B. Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration. Tissue Eng. 2004;10:942-54.
66. Catelas I, Sese N, Wu BM, Dunn JC, Helgerson S, Tawil B. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng. 2006;12: 2385-96.
67. Ferguson WD, Collins LM, Smith DW. Psychophysical threshold variability in cochlear implant subjects. Hear Res. 2003;180:101-13.
68. Tassiopoulos AK, Golts E, Oh DS, Labropoulos N. Current concepts in chronic venous ulceration. Eur J Vasc Endovasc Surg. 2000;20:227-32.
69. Nakatsu MN, Hughes CCW. An optimized three-dimensional in vitro model for the analysis of angiogenesis. Methods Enzymol. 2008;443:65-82.
70. Nehls V, Drenckhahn D. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc Res. 1995;50:311-22.
71. Montano I, Schiestl C, Schneider J, Pontiggia L, Luginbühl J, Biedermann T, Böttcher-Haberzeth S, Braziulis E, Meuli M, Reichmann E. Formation of human capillaries in vitro: the engineering of prevascularized matrices. Tissue Eng Part A. 2009;15:1-15.
72. Carmeliet P, Conway EM. Growing better blood vessels. Nat Biotechnol. 2001;19:1019-20.
73. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407:242-8.
74. Chen Z, Htay A, Dos Santos W, Gillies GT, Fillmore HL, Sholley MM, Broaddus WC. In vitro angiogenesis by human umbilical vein cells (HUVEC) induced by three-dimensional coculture with glioblastoma cells. J Neurooncol. 2009;92:121-8.
75. Nakatsu MN, Sainson RC, Aoto JN, Taylor KL, Aitkenhead M, Pérez-del-Pulgar S, Carpenter PM, Hughes CC. Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and angiopoietin-1. Microvasc Res. 2003;66:102-12.
76. Sukmana I, Vermette P. Polymer fibers as contact guidance to orient microvascularization in a 3D environment. J Biomed Mater Res A. 2010;92:1587-97.
77. Sukmana I, Vermette P. The effect of co-culture with fibroblast and angiogenic growth factors on microvascular maturation and multi-cellular lumen formation in HUVEC-oriented polymer fibre constructs. Biomaterials. 2010;31:5100-9.
78. Lishko VK, Kudryk B, Yakubenko VP, Yee VC, Ugarova TP. Regulated unmasking of the cryptic binding site for integrin alpha M beta 2 in the gamma C-domain of fibrinogen. Biochemistry. 2002;41:12942-51.
79. Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell. 1989;58:945-53.
80. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem. 2005;70:247-99.
81. Monchaux E, Vermette P. Effects of surface properties and bioactivation of biomaterials on endothelial cells. Front Biosci (Schol Ed). 2010;2:239-55.
82. Bayless KJ, Davis GE. Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. Biochem Biophys Res Commun. 2003;312:903-13.
83. Isenberg BC, Williams C, Tranquillo RT. Small-diameter artificial arteries engineered in vitro. Circ Res. 2006;98:25-35.
84. Mooney DJ, Organ G, Vacanti JP, Langer R. Design and fabrication of biodegradable polymer devices to engineer tubular tissues. Cell Transplant. 1994;3:203-10.
85. Mooney DJ, Mazzoni CL, Breuer C, McNamara K, Hern D, Vacanti JP, Langer R. Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials. 1996;17:115-24.
86. Lesman A, Blinder Y, Levenberg Y. Modeling of flow-induced shear stress applied on 3D cellular scaffolds: implications for vascular tissue engineering. Biotechnol Bioeng. 2010;105: 645-54.
87. Davis GE, Black SM, Bayless KJ. Capillary morphogenesis during human endothelial cell invasion of three-dimensional collagen matrices. In Vitro Cell Dev Biol Anim. 2000;36:513-9.
88. Kannan RY, Salacinski HJ, Sales K, Butler P, Seifalian AM. The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials. 2005;26:1857-75.
89. Agrawal CM, Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res. 2001;55:141-50.
90. Linnes MP, Ratner BD, Giachelli CM. A fibrinogen-based precision microporous scaffold for tissue engineering. Biomaterials. 2007;28:5298-306.
91. Clowes AW, Kirkman TR, Clowes MM. Mechanisms of arterial graft failure. II. Chronic endothelial and smooth muscle cell proliferation in healing polytetrafluoroethylene prostheses. J Vasc Surg. 1986;3:877-84.
92. O'Brien FJ, Taylor D, Clive LT. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials. 2005;26: 433-41.
93. Zeltinger J, Sherwood JK, Graham DA, Müeller R, Griffith LG. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng. 2001;7:557-72.
94. Huang Y, Onyeri S, Siewe M, Moshfeghian A, Madihally SV. In vitro characterization of chitosan-gelatin scaffolds for tissue engineering. Biomaterials. 2005;26:7616-27.
95. Zhang Z, Wang Z, Liu S, Kodama M. Pore size, tissue ingrowth, and endothelialization of small-diameter microporous polyurethane vascular prostheses. Biomaterials. 2004;25:177-87.
96. Marshall A, Barker T, Sage E, Hauch K, Ratner B. Pore size controls angiogenesis in subcutaneously implanted porous matrices. In: 7th World Biomaterials Congress, Sydney; 2004.
97. Yao L, Swartz DD, Gugino SF, Russell JA, Andreadis ST. Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity. Tissue Eng. 2005;11:991-1003.
98. Geiger B, Bershadsky A, Pankov R, Yamada KM. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol. 2001;2:793-805.
99. Ingber DE, Prusty D, Sun Z, Betensky H, Wang N. Cell shape, cytoskeletal mechanics and cell cycle control in angiogenesis. J Biomech. 1995;28:1471-84.
100. Pelham RJ, Wang Y. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc Natl Acad Sci USA. 1997;94:13661-5.
101. Tseng Q, Wang I, Duchemin-Pelletier E, Azioune A, Capri N, Gao J, et al. A new micropatterning method of soft substrates reveals that different tumorigenic signals can promote or reduce cell contraction levels. Lab Chip. 2011;11:2231-40.
102. Discher DE, Janmey P, Wang YL. Tissue cells feel and respond to the stiffness of their substrate. Science. 2005;310:1139-43.
103. Lo CM, Wang HB, Dembo M, Wang YL. Cell movement is guided by the rigidity of the substrate. Biophys J. 2000;79: 144-52.
104. Deroanne CF, Lapiere CM, Nusgens BV. In vitro tubulogenesis of endothelial cells by relaxation of the coupling extracellular matrix-cytoskeleton. Cardiovasc Res. 2001;49:647-58.
105. Yeung T, Georges PC, Flanagan LA, Marg B, Ortiz M, Funaki M, Zahir N, Ming W, Weaver V, Janmey PA. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil Cytoskelet. 2005;60:24-34.
106. Duong H, Wu B, Tawil B. Modulation of 3D fibrin matrix stiffness by intrinsic fibrinogen-thrombin compositions and by extrinsic cellular activity. Tissue Eng Part A. 2009;15:1865-76.
107. Man AJ, Davis EH, Itoh A, Leach JK, Bannerman P. Neurite outgrowth in fibrin gels is regulated by substrate stiffness. Tissue Eng Part A. 2011;17:2931-42.